John Fallon
Nurse Practitioner · Hyde Park, NYNPI 1265655252
Payments from drug & device makers
Across 102 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$477
- Takeda Pharmaceuticals U.S.A., Inc.$458
- AbbVie$243
- Lilly USA, LLC$238
- Pfizer$209
- Grifols USA, LLC$88
- plus $304 from 11 others
What the payments were for
- Food & beverage$2,017100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 22 | $477 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $458 |
| AbbVie | 12 | $243 |
| Lilly USA, LLC | 11 | $238 |
| Pfizer | 11 | $209 |
| Grifols USA, LLC | 5 | $88 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $59 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Octapharma USA, Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Argenx US, Inc. | 1 | $20 |
| Bio Products Laboratory USA, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$2,017 in reported general payments places this provider in the 90th percentile of 4,112 nurse practitioner providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Leucovorin Calcium | 65 | $54,689 |
| XifaxanRifaximin | 13 | $42,281 |
| Atovaquone-Proguanil HclAtovaquone/Proguanil Hcl | 40 | $14,088 |
| Pyrazinamide | 48 | $12,243 |
| Nystatin | 149 | $8,247 |
| Atovaquone | 12 | $8,147 |
| Dapsone | 52 | $4,022 |
| Rifampin | 85 | $3,223 |
| Minocycline Hcl | 78 | $2,566 |
| Doxycycline Hyclate | 39 | $2,303 |
| Azithromycin | 99 | $2,186 |
| SynthroidLevothyroxine Sodium | 17 | $1,543 |
| Famciclovir | 19 | $1,531 |
| Hydroxychloroquine Sulfate | 62 | $1,474 |
| ValacyclovirValacyclovir Hcl | 26 | $1,214 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $34 | $42,28113 claims |
| AbbVieSynthroid, Armour Thyroid | $243 | $1,85328 claims |
| PfizerLevoxyl | $209 | $28013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,112 nurse practitioner providers in New York.
Other nurse practitioner in Hyde Park
- Patricia McGoldrickNew York$202K
- Michelle DartSyracuse$95K
- Susan KreppelWilliamsville$67K
- Kerry AhernEast Syracuse$55K
- Valerie StanleyAlbany$55K
- Jodi LogerfoNew York$48K
- Grace WlasowiczRochester$41K
- Melissa LevinElmhurst$34K
- Carla JungquistCanandaigua$28K
- Kelly WilmarthJohnson City$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.